Associate Director, Biostatistics at Eikon Therapeutics

Jersey City, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalIndustries

Requirements

PhD or equivalent degree in statistics/biostatistics or related discipline with a minimum of 6 years of clinical research and drug development experience
Proficiency in statistical programming languages (e.g., R, SAS) and experience with data visualization tools
Strong understanding of regulatory guidelines (ICH, FDA, etc.) and their implications on statistical analysis and reporting
Experience in authoring statistical analysis plans and performing statistical analyses and reporting using tables, listings, and figures (oncology experience is a plus)
Excellent communication skills with the ability to convey complex statistical concepts to non-technical stakeholders
Demonstrated leadership capabilities, including the ability to lead and mentor a team
Experience with Bayesian statistics and adaptive trial designs
Publications in peer-reviewed journals showcasing contributions to the field of biostatistics
Proven track record of designing and analyzing clinical trials and experimental studies, particularly within the biotechnology, pharmaceutical, or related industries
Minimum of 3 days a week onsite presence in New Jersey office (or more as business needs require)

Responsibilities

Collaborate with interdisciplinary teams to design clinical trials, experiments, and studies, ensuring appropriate statistical methodologies are employed
Lead the development of statistical analysis plans, including endpoints, sample size determination, randomization strategies, and statistical methodologies
Perform advanced statistical analyses on complex datasets, interpreting results and drawing actionable conclusions
Provide guidance and mentorship to biostatisticians and statistical programmers within the team
Contribute to regulatory submissions by providing statistical expertise and preparing relevant sections of documents
Stay current with emerging trends and best practices in biostatistics and their application in the biotechnology field
Drive the implementation and utilization of advanced statistical tools and software

Skills

Biostatistics

Clinical Trial Design

Statistical Analysis

Statistical Programming

SAS

Regulatory Guidelines

SAP

Study Analysis

Eikon Therapeutics

Biotech startup developing innovative medicines

About Eikon Therapeutics

Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company employs advanced technologies to study biological systems, aiming to identify new drug targets by examining the dynamic aspects of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that aim to improve and extend life. A key feature of Eikon's approach is their proprietary single-molecule tracking (SMT) platform, which enables rapid visualization of protein movements in living cells. This technology, along with artificial intelligence and automation, allows for precise inventorying of molecular interactions. Eikon Therapeutics targets patients with serious diseases who need effective treatments, generating revenue through the development and commercialization of their therapies.

Hayward, CaliforniaHeadquarters

2019Year Founded

$750.8MTotal Funding

SERIES_CCompany Stage

AI & Machine Learning, BiotechnologyIndustries

201-500Employees

Benefits

401(k) Company Match

Medical (premiums covered by Eikon at 95%)

Dental Insurance

Vision Insurance

Mental Health Support

Unlimited Paid Time Off

Paid Holidays

Life Insurance

Enhanced Parental Leave

Daily subsidized lunch program

Risks

Competition from biotech unicorns like Abogen Biosciences is increasing.

Integrating new clinical-stage assets may delay drug development timelines.

Reliance on SMT technology risks obsolescence from emerging molecular biology technologies.

Differentiation

Eikon uses proprietary single-molecule tracking for real-time protein movement analysis.

The company integrates AI and automation for large-scale molecular interaction studies.

Eikon's diverse team combines expertise in science, engineering, and technology.

Upsides

Growing interest in SMT technology boosts Eikon's drug discovery potential.

Partnerships with AI firms enhance Eikon's drug candidate identification.

Rising demand for precision medicine aligns with Eikon's focus on dynamic biology.

Land your dream remote job 3x faster with AI

Try Jobo Free